Table 2.
Recurrent versus non-recurrent patients
| Recurrent | Non-recurrent | p value | |
|---|---|---|---|
| Gender | |||
| Male | 10 | 10 | 0.7739 |
| Female | 3 | 7 | 0.7110 |
| Total | 13 | 17 | 0.4404 |
| Stage, n (%) | |||
| IA | 1 (3.33) | 0 (0) | 0.3182 |
| IB | 0 (0) | 1 (3.33) | 0.3182 |
| IIA | 0 (13.34) | 4 (13.34) | 0.1445 |
| IIB | 12 (50) | 12 (50) | 0.7843 |
| Age (years) | |||
| Range | 47.9–84.5 | 50.4 – 82.6 | 0.8220 |
| Median | 61.6 | 64.6 | |
| Adjuvant therapy (yes), n (%) | 12 (92.3) | 13 (76.5) | 0.7899 |
| Tumor size (cm) | |||
| Range | 1.8–5.2 | 1.4–5.5 | 0.6021 |
| Mean | 3.1 | 3.35 | |
| R0 resection (yes), n (%) | 12 (92.31) | 16 (94.12) | 1.0000 |
| Perineural invasion (yes), n (%) | 2 (15.38) | 2 (11.76) | 1.0000 |
| Lymphovascular invasion (yes), n (%) | 9 (69.23) | 10 (58.82) | 0.7080 |
| Lymph node status | |||
| No. of positive | 6 | 3.18 | |
| No. of examined | 22.38 | 21.08 | |
| % positive (mean) | 28.36 | 13.44 | 0.0247 |
Comparison of recurrent with non-recurrent patients shows that there are no differences in gender, age, or tumor stage between these groups, and that a similar number of patients in each group received adjuvant radiochemotherapy. No differences were detected in tumor size, perineural or lymphovascular invasion, or R0 resection, but there is a statistically significant difference in the number of positive lymph nodes in the recurrent versus non-recurrent group